Gregory T. Hebrank

Knopp Neurosciences, Inc. operates as a drug discovery and development company. It focused on delivering breakthrough treatments in neurological disorders. It operates through three areas: inflammation discovery platform, mitochondrial discovery platform, and ion channel discovery platform. The company was founded by Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.

Crystalplex Corp. operates a biochemistry and diagnostics laboratory that specializes in nanotechnology for the life sciences industry. Its proprietary technology, SapphireTM QDs provides a stable crystal design, flexible polymer matrix morphology, and meets environmentally responsible yet demanding performance requirements for high-end consumer electronics applications such as liquid crystal display televisions, displays, and high-CRI architectural lighting. The company was founded by Thomas A. Petzinge Jr. in 2004 and is headquartered in Pittsburgh, PA.

Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.

Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA.

LaunchCyte LLC (LaunchCyte) is a venture capital firm founded in 2000 by Tom A.Petzinger and Barbara Bailey Carryer. The firm is headquartered in Pittsburgh, Pennsylvania.